Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1708 of 5804
-
Pharmacists take on polypharmacy: can a bundled care model cut costs and improve safety?
Disease control Not yet recruitingThis study aims to evaluate whether a clinical pharmacist-led bundled care model can improve medication use and health outcomes in hospitalized adult patients with preventable polypharmacy. Preventable polypharmacy refers to the use of multiple medications when some may no longer…
Phase: NA • Sponsor: Sultan Qaboos University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New beads could ease pain after spine surgery
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if using calcium sulfate beads that contain vancomycin (an antibiotic) and pain-relieving medicines during spine surgery can improve recovery compared to standard care with intravenous (IV) morphine and local pain medicines. Researcher…
Phase: PHASE2 • Sponsor: Ganesh M. Shankar • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Adapted exercise program aims to boost health and social skills in visually impaired youth
Symptom relief Not yet recruitingVisual impairment (VI) has significant implications not only for visual functioning, but also for the motor development, psychological well-being, and social participation of children and adolescents. Despite the fundamental role of physical activity in promoting health, autonomy…
Phase: NA • Sponsor: Università degli Studi di Trento • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Which IV drug tames a racing heart in AFib faster? a Head-to-Head trial
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether intravenous verapamil or intravenous metoprolol controls heart rate more effectively in adult patients who arrive at the emergency department with atrial fibrillation and a fast heart rate (rapid ventricular response), but who a…
Phase: PHASE4 • Sponsor: Muhammad Ali Javed • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Ancient herbal mix targets dual gut disorders in one shot
Disease control Not yet recruiting1. To conduct a multicenter, randomized controlled trial across four hospitals to evaluate the efficacy of Hewei Anchang Formula in patients with overlapping gastrointestinal symptoms of functional dyspepsia (FD) and diarrhea-predominant irritable bowel syndrome (IBS-D), characte…
Phase: NA • Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Skin gel targets immune signals in rare lymphoma
Disease control Not yet recruitingThis study will evaluate the safety and preliminary efficacy of duvelisib topical gel in participants with early-stage mycosis fungoides.
Phase: PHASE1 • Sponsor: SecuraBio • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Which walking workout best helps stroke survivors walk again?
Symptom relief Not yet recruitingThe purpose of this study is to elucidate optimal dosing for High Intensity Gait Training (HIGT) to reduce locomotor disability for those undergoing inpatient rehabilitation (IR) in the subacute phase of stroke recovery. This is a randomized controlled trial conducted at a singl…
Phase: NA • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
New hope for MS muscle stiffness: phase 3 drug trial launches
Symptom relief Not yet recruitingThis is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the safety and efficacy of oral arbaclofen ER tablets in MS patients with spasticity. Arbaclofen ER will be compared with placebo.
Phase: PHASE3 • Sponsor: RVL Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
New combo therapy targets ringing ears without drugs
Symptom relief Not yet recruitingTinnitus (ringing or buzzing in the ears) affects approximately 10-15% of the adult population and significantly reduces quality of life in many patients. In a substantial proportion of cases, tinnitus is associated with dysfunction of the temporomandibular joint (TMJ) and cervic…
Phase: NA • Sponsor: Charles University, Czech Republic • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Which autism therapy works best? new study aims to find out
Symptom relief Not yet recruitingThe goal of this study is to compare two well-established early autism interventions, Early Start Denver Model (ESDM) and Pivotal Response Treatment (PRT), to better understand which approach is most effective for improving communication skills in young children with autism and w…
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
New MRI technique could slash radiation in bone cancer surgeries
Diagnosis Not yet recruitingThe goal of this exploratory interventional study aims to evaluate the performance of "pseudo-scanner" MRI sequences in delineating the tumor extent within bone sarcomas and its ability to serve as a reference for designing cutting guides and enabling "navigation" during the surg…
Phase: NA • Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
Pharmacy techs may unlock HIV shot access for hundreds
Disease control Not yet recruitingLong-acting injectable HIV medication is an important new innovation in HIV treatment, but complex delivery logistics have resulted in limited access for people with HIV (PWH). The goal of this study is to use clinic-based pharmacy technicians to improve delivery of long-acting i…
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Could placental stem cell vesicles ease COVID-19?
Symptom relief Not yet recruitingInvestigational New Drug trial investigating safety as primary endpoint and clinical efficacy as secondary endpoint of placental, mesenchymal stem cell-derived extracellular vesicles for the treatment of COVID-19 symptoms in adults with mild to moderate illness.
Phase: PHASE1, PHASE2 • Sponsor: Kimera Labs Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Could a daily leg warming session improve walking for PAD patients?
Symptom relief Not yet recruitingLower-extremity peripheral artery disease is associated with impaired walking ability, reduced lower-extremity function, and decreased quality of life. This randomized, sham-controlled clinical trial will evaluate the effects of 12 weeks of home-based lower-extremity heat therapy…
Phase: NA • Sponsor: Aquilo Sports, LLC • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could pomegranate supplements help heal the gut in Alcohol-Related liver disease?
Knowledge-focused Not yet recruitingThe goal of this project is to determine an individual's ability to generate active gut microbial metabolites called urolithins upon consumption of pomegranate dietary supplements. Recent publications have reported that urolithins are the major active metabolites responsible for …
Sponsor: University of Louisville • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Could stem cells help women with thin uterine lining get pregnant?
Disease control TerminatedTo explore the therapeutic effect and safety of human umbilical cord mesenchymal stem cells on thin endometrial infertility and to explore whether human umbilical cord mesenchymal stem cells using collagen as the carrier can promote endometrial growth, reduce the recurrence rate …
Phase: PHASE1 • Sponsor: Sclnow Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Stem cell hope for bone marrow disease
Disease control TerminatedThe purposes of the study is to determine the safety and efficacy of human umbilical cord mesenchymal stem cells (hUC-MSC) in treating Myelodysplastic Syndrome patients.
Phase: PHASE1, PHASE2 • Sponsor: Sclnow Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Cord blood stem cells tested in stroke patients – early safety check
Disease control TerminatedThe purposes of the study is to determine the safety and efficacy of treating acute ischemic stroke patients with human umbilical cord mesenchymal stem cells (hUC-MSC).
Phase: PHASE1 • Sponsor: Sclnow Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New stimulation device hopes to restore limb function after brain and spinal injuries
Disease control Not yet recruitingThis study will evaluate the safety and performance of the Spatial StimeMD (SSMD) medical device in people with multiple sclerosis (MS). The SSMD device is intended to support patients through a non-invasive stimulation program. The study will assess changes in MS-related symptom…
Phase: NA • Sponsor: Motion Informatics LTD • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Digital coach helps kids heal after heart surgery
Symptom relief Not yet recruitingThe goal of this clinical trial is to evaluate whether a Just-in-Time Adaptive Intervention (JITAI)-based digital exercise rehabilitation program can improve postoperative recovery in children after congenital heart disease (CHD) surgery. The study will examine whether this syste…
Phase: NA • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC